InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-9.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Egan Dwight H, Chairman & CEO. Director active across 2 companies, notably Co-Diagnostics, Inc.. Cumulatively, 12 reports have been published. History available since 24 May 2021. The latest transaction was filed on 23 May 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
4,584 shares0Common StockSEC:0001712187-26-000002:0
1,633 shares@ US$5.070.15% mcap100.0% of flowCommon StockSEC:0001712187-26-000002:1
163,333 shares0Common StockSEC:0001562180-24-007928:0
138,333 shares0Common StockSEC:0001562180-24-004436:0
150,834 shares0Common StockSEC:0001562180-23-007921:0
105,000 shares0Common StockSEC:0001562180-23-004444:0
79,166 shares0Common StockSEC:0001562180-22-007852:0
33,334 shares0Common StockSEC:0001562180-22-004379:0
33,333 shares0Common StockSEC:0001562180-21-007256:0
33,333 shares0Common StockSEC:0001562180-21-007256
12,500 shares0Common StockSEC:0001562180-21-003741
12,500 shares0Common StockSEC:0001562180-21-003741:0
12 of 12 declarations
About Egan Dwight H
Dwight H. Egan is the Chief Executive Officer at Co-Diagnostics, Inc. In this role, he is responsible for the strategic and operational direction of the company. Egan plays a key role in making decisions that influence the future direction of the organization. His expertise in biotechnology and management is essential for the success of the company.
